NEW YORK, March 25, 2021 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK livestream investor conferences, and investor LiveChats on social media streams. Over 160,000 investors have participated in Wall Street Reporters livestream events in the past 30 days.
Interactive Games Technologies (CSE: BETS) (OTC: BLITF), CEO Chris Neville: "Building Next Billion Dollar Global Betting Giant"
In a recent interview at Wall Street Reporters NEXT SUPER STOCK livestream, Interactive Games Technologies (OTC: BLITF) (CSE: BETS) CEO Chris Neville, shares his companys ambitious global strategy, with a unique focus on India. As a pioneer of online gaming with almost 20 year's experience, Neville sees a strong parallel between the poker boom of the early 2000s and the Indian market today.
Watch (CSE: BETS) (OTC: BLITF) NEXT SUPER STOCK Video: http://bit.ly/2Zuubon
India is one of the fastest growing online gaming markets in the world. With a growing population, especially the middle class, a burgeoning economy, the fastest internet adoption in the world, and with 65% of the population under the age of 35, India is the perfect storm for skill based online gaming.
Interactive Games Technologies (OTC: BLITF) (CSE: BETS) sees India as the perfect launchpad for its global betting business, with relatively low customer acquisition costs, less competition, and blue sky upside potential. By partnering with Indian social influencers such Bollywood celebrities and cricket stars, BLITF reaches their 150 million followers in India. BLITF is also expanding into new untapped global gaming markets such Canada which is about to legalize sports betting.
March 23 - BLITF reports that launch of its recently acquired skill-based fantasy gaming product, BLITZPOOLS, is exceeding expectations. BLITZPOOLS is already over 150,000 new registrations and expects to close the month with over 250,000 new players. It is clear the industry leading product and brand positioning is resonating with the Indian fantasy gaming audience, and is now one of Indias fastest-growing skill-based fantasy sports platforms.
Story continues
March 16 - BLITF announces plans to enter US gaming market. BLITF management is in talks with US land-based casino to partner in building and managing a digital gambling platform and offering. Morgan Stanley estimates that the U.S. online gambling market (sports betting and iGaming) will soon top $20 billion Gross Gaming Revenue per year. The lack of permissive online gambling regulations until recently in the U.S. means that online gambling experience is limited in the U.S. market. Online gambling has, however, been permitted in other countries and regions for over two decades. BLITF has assembled a team of online gambling executives, with over 100 years online gambling experience, and believes can provide land-based operators with the knowledge, experience and expertise to capitalise on the growing US online gambling market. BLITF CEO, Chris Neville said: The Company is hugely excited by this opportunity in the burgeoning U.S. online gambling market. We have a great team and a great partner to add significant value to future potential partners in this space.
March 8 - BLITF announces signing of rising cricket stars Ishan Kishan, Rahul Chahar, Shreyas Gopal and Wriddhiman Saha to be the face of the brand. Attracting their ever-growing and large fan base to the app, the cricketer quartet will be an integral part of the 360-degree digital and offline campaign activation of BLITZPOOLS. In addition to these cricket stars and as part of the new brand launch, BLITZPOOLS has engaged celebrities and influencers alike with a total follower count in excess of 215 million, the identities of which will be revealed at time of post and in a future release.
Watch (CSE: BETS) (OTC: BLITF) NEXT SUPER STOCK Video: http://bit.ly/2Zuubon
Hapbee Technologies (OTC: HAPBF) CEO Scott Donnell: Tech That Lets You Choose How you Feel = Billion Dollar Market OpportunityOne of the most unique companies to present at Wall Street Reporters NEXT SUPER STOCK livestream events in recent years, is Hapbee Technologies (OTC: HAPBF) which markets wearable tech that lets you choose feelings on demand. The patented technology uses low-power electromagnetic signals designed to produce sensations such as Happy, Alert, Focus, Relax, Calm and Sleepy. HAPBF is developing new feeling signals regularly which are available on a subscription basis through its mobile app.
In his interview with Wall Street Reporter, Hapbee CEO Scott Donnell explains how Hapbees technology platform addresses untapped multi-billion dollar market opportunities which include mental health, sleep, and fitness, among other aspects of our daily lives which are impacted by feelings. Scott also shares HAPBFs unique D2C e-commerce strategy which is based on proven systems of todays most successful billion-dollar D2C fitness, health and lifestyle brands. Hapbee is rapidly being embraced by influencers in fitness/wellness, biohackers, and high-performance executives who want to perform and feel their best. HAPBF unique technology positions it at the forefront of the fast growing $32 billion wearable tech market.
Watch Hapbee Technologies (OTC: HAPBF) NEXT SUPER STOCK Video: http://bit.ly/3vh6Ncx
ESE Entertainment (TSX.V: ESE) (OTC: ENTEF) CEO Konrad Wasiela: E-Sports M&A Pipeline With Over $100 million Annual Revenues
ESE Entertainment (TSX.V: ESE) (OTC: ENTEF) CEO Konrad Wasiela, a featured presenter at Wall Street Reporters NEXT SUPER STOCK investors livestream conference, recently updated investors on his goal of building ESE into a billions dollar global enterprise. Wasiela shared that ESE now has a growing M&A pipeline with over $100 million annual revenues and expected to close a significant number of these potential transactions in the coming months. ESEs stated goal is to build a global E-Sports business with a valuation of $1 Billion+.
Watch ESE (OTC: ENTEF) Next Super Stock livestream video: https://bit.ly/3qq59mb
In his interview with Wall Street Reporter, ESE CEO Konrad Wasiela, says the company is now ready to scale - expanding its global footprint, with new partnerships with global brands like Porsche, driving revenue growth with aggressive focus on top line sales and margin expansion, and M&A opportunities. ESE is now rapidly expanding, with multiple revenue streams including, E-Sports infrastructure software powering global tournaments, exclusive digital media distribution, broadcast rights, and owning world-class leagues and teams, including its K1CK global E-Sports franchise.
March 17 - ENTEF announces launch of Virtual Pitstop, a new business unit dedicated to simulation racing (sim racing). Virtual Pitstop will provide technology for video game developers, racing fans, and gamers to engage in motorsport related esports across the globe. ENTEF CEO Konrad Wasiela, commented, We are excited to announce the expansion of our digital Motorsport business with the launch of the Virtual Pitstop brand. Our past successful partnerships and business collaborations with Porsche, Kia, and Orlen are just the beginning. We see a significant opportunity to implement fast growing technology and monetization via AR/VR, NFTs, skins, and more.
Watch ESE (OTC: ENTEF) Next Super Stock livestream video: https://bit.ly/3qq59mb
Delic Holding (CSE: DELC) (OTC: DELCF) CEO Matt Stang: Psychedelics For Mental Health Is Major Growth Trend
In a recent interview at Wall Street Reporters Investors Discovery Day livestream, Delic Holdings (OTC: DELCF) CEO Matt Stang shared his unique strategy for capitalizing on what is expected to be the next massive new market opportunity: psychedelics. As the former publisher of High Times Magazine over 14 years, Matt Stang paved the way for cannabis legalization, and along the way, developed a network of industry pioneers who are now active in the psychedelics space. In his interview, Stang explains DELCFs unique psychedelics ecosystem business model - which offers synergies, and leverage - and generates revenues across the entire psychedelics value chain.
DELCFs ecosystem spans across an online media platform which provides consumers information and reviews, on psychedelics - an expanding chain of ketamine treatment clinics - to a licensed research lab developing innovative psychedelics product formulations - to clinical research data for biotech & pharma for developing new psychedelic compounds. DELCF intends to expand this ecosystem further, through M&A, leveraging Matt Stangs 14 years of experience and wide industry contacts across the industry.
Watch DELCF NEXT SUPER STOCK video: http://bit.ly/3uK4L4y
March 5 - DELCF announces acquisition of the Homestead brand and intellectual property. Homestead is a legacy counterculture distributor of psychedelic media and creator of one of the first self-contained mushroom grow kits. Matt Stang, Founder and CEO of DELCF commented, "The acquisition of Homestead is an exciting one for us at DELIC. It shows how we are increasing accessibility to this nascent industry within regulated jurisdictions. Homestead not only sold tens of thousands of mushroom kits globally but also was one of the earliest distributors for High Times and many other counter culture publications. We look forward to growing together and increasing shareholder value with what we accomplish."
February 25 - DELCF announces acquisition of Complex Biotech Discovery Ventures, a licensed psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development. Founded by award-winning chemist, Dr. Markus Roggen, and UBC Professor, Glenn Sammis, CBDV supports the psychedelic industry with high precision chemical analytics and metabolomic identification.
Watch DELCF NEXT SUPER STOCK video: http://bit.ly/3uK4L4y
WALL STREET REPORTER
Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO's of promising, publicly-traded companies, and market experts. http://www.WallStreetReporter.com. Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context. Full disclaimer, and relevant SEC 17B disclosures here: http://bit.ly/39kkE7K
About Wall Street Reporters Next Super Stock conference:
Wall Street Reporter's NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event: https://www.wallstreetreporter.com/next-superstock-online-investor-conference/
CONTACT:
WALL STREET REPORTER
(212) 871-2057 ext 7
http://www.WallStreetReporter.com
Here is the original post:
- Review: Tripping on Utopia Complicates the History of Psychedelics - AOL - March 16th, 2024 [March 16th, 2024]
- Psychedelics Are Going Mainstream. Investing in Them Hasn't. - The Wall Street Journal - January 7th, 2024 [January 7th, 2024]
- Another Study Shows African Psychedelic Plant Ibogaine Treats Traumatic Brain Injury in Vets With 'Dramatic' Results - Good News Network - January 7th, 2024 [January 7th, 2024]
- Massachusetts Lawmakers Will Be Forced To Consider Psychedelics Legalization Measure That Activists Petitioned ... - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA to begin researching psychedelics as treatment option for veterans - Government Executive - January 5th, 2024 [January 5th, 2024]
- VA Is Funding New Research On Psychedelics' Benefits For Veterans With PTSD And Depression - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA ramps up study of psychedelic to treat PTSD - The American Legion - January 5th, 2024 [January 5th, 2024]
- Scientists predict DMT trip from cardiac activity - Big Think - January 5th, 2024 [January 5th, 2024]
- If psychedelics heal, how do they do it? | Proceedings of the National Academy of Sciences - pnas.org - January 5th, 2024 [January 5th, 2024]
- Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential | Molecular ... - Nature.com - January 5th, 2024 [January 5th, 2024]
- U.S. Rep. Correa supports using psychedelics to treat veterans with PTSD - New Santa Ana - January 5th, 2024 [January 5th, 2024]
- DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Psychedelics for Psych Conditions Made Their Mark in 2023 - Medpage Today - January 5th, 2024 [January 5th, 2024]
- 2023: A Good Trip Around the Sun for Psychedelics - The National Law Review - January 5th, 2024 [January 5th, 2024]
- Understanding the Role of the FDA in Advancing Psychedelic Therapy - Medriva - January 5th, 2024 [January 5th, 2024]
- MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics - Psychedelic Alpha - January 5th, 2024 [January 5th, 2024]
- Closing the innovation gap: Advancing psychedelic therapy and medicines in EU mental health care - Open Access Government - January 5th, 2024 [January 5th, 2024]
- The Austin Chronic: SXSW Is High on Psychedelics, as Cannabis Programming Wanes - Austin Chronicle - January 5th, 2024 [January 5th, 2024]
- This Forgotten Psychedelic Could Revolutionize Traumatic Brain Injury Treatment - Inverse - January 5th, 2024 [January 5th, 2024]
- A 'milestone' for psychedelics: Pentagon directed to study alternative treatments for veterans - Washington Times - January 5th, 2024 [January 5th, 2024]
- Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here's What's Next - Singularity Hub - January 5th, 2024 [January 5th, 2024]
- The top 8 psychedelic books you need to read | GreenState - GreenState - January 5th, 2024 [January 5th, 2024]
- Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC - Green Market Report - January 5th, 2024 [January 5th, 2024]
- DEA Calls For Even More THC, Psilocybin And DMT To Be Produced For Research In 2024 - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Here's What You Missed in Cannabis, Psychedelics This Week - TipRanks.com - TipRanks - January 5th, 2024 [January 5th, 2024]
- You're not tripping: State and local leaders give psychedelics another chance - Route Fifty - December 22nd, 2023 [December 22nd, 2023]
- Are Consciousness-Expanding Psychedelics Like Psilocybin More Effective Than Prozac, Zoloft, Xanax, and Other ... - Nautilus - December 22nd, 2023 [December 22nd, 2023]
- RFK, Ramaswamy And Williamson Push Psychedelics Reform On Presidential Campaign Trail - Marijuana Moment - December 22nd, 2023 [December 22nd, 2023]
- Peyote is the darling of the psychedelics renaissance. Indigenous users say it co-opts a sacred way of life - The Guardian US - December 22nd, 2023 [December 22nd, 2023]
- USask researchers explore untold history of psychedelics - News - University of Saskatchewan - USask News - December 22nd, 2023 [December 22nd, 2023]
- California Governor Says Psychedelics Have 'Profound' Healing Potential, But He's Undecided On Legalization Bill As ... - Marijuana Moment - September 25th, 2023 [September 25th, 2023]
- As psychedelic-assisted therapy grows, so does interest from a new group: chaplains - NPR - September 25th, 2023 [September 25th, 2023]
- This Maine City Moves Unanimously On Decriminalizing Psychedelics: Focus On Public Health - Benzinga - September 25th, 2023 [September 25th, 2023]
- Tech Leaders Are Finding Balance Through Microdosing Psychedelics - The Dales Report - September 25th, 2023 [September 25th, 2023]
- Chronic Pain Can Be Treated by Psychedelics, Survey Suggests - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Insights Into the First Psychedelic-Assisted Therapy Guidelines With ... - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Living with long-term cancer is depressing. Texas doctors say psychedelics could help - The Hill - July 19th, 2023 [July 19th, 2023]
- Couples Are Doing MDMA and Ketamine Therapy To Save Their Relationships - VICE - July 19th, 2023 [July 19th, 2023]
- The Way People Are Using Psychedelics Is Changing Amid Reform ... - Marijuana Moment - July 19th, 2023 [July 19th, 2023]
- [WATCH] Turn on, tune in, legalise: Could psychedelics be next in ... - MaltaToday - July 19th, 2023 [July 19th, 2023]
- Will Psychedelics Be Rescheduled After FDA Approval? - Harris Bricken - July 19th, 2023 [July 19th, 2023]
- The Psychedelic Preparedness Scale: A Tool to Optimize Trip ... - Filter - July 19th, 2023 [July 19th, 2023]
- How to Test Psychedelics for Adulterants with Testing Kits - Psychedelic Spotlight - July 19th, 2023 [July 19th, 2023]
- Cannabis Science Conference to debut in Providence, R.I., with ... - GlobeNewswire - July 19th, 2023 [July 19th, 2023]
- New Speaker Rivas weighs in on psychedelics, housing and health care worker minimum wage - Yahoo News - July 19th, 2023 [July 19th, 2023]
- TDR's Top 5 Psychedelic Developments For The Week Of July 10 - The Dales Report - July 19th, 2023 [July 19th, 2023]
- Psychedelic Treatment with Psilocybin Relieves Major Depression, Study ... - February 20th, 2023 [February 20th, 2023]
- Johns Hopkins Launches Center For Psychedelic Research - February 20th, 2023 [February 20th, 2023]
- Psilocybin Treatment for Major Depression Effective for Up to a Year ... - February 20th, 2023 [February 20th, 2023]
- Inside the Johns Hopkins Psilocybin Playlist - Hopkins Medicine - February 20th, 2023 [February 20th, 2023]
- Research Story Tip: Psychedelic Drug Psilocybin Tamps Down Brains Ego ... - February 20th, 2023 [February 20th, 2023]
- Psychedelics: Risks, benefits, and more - Medical News Today - February 18th, 2023 [February 18th, 2023]
- Psychedelic Drug Effects, Side Effects & Dangers - January 25th, 2023 [January 25th, 2023]
- Psychedelics Decriminalization Project In Berkeley, Cal Includes ... - January 6th, 2023 [January 6th, 2023]
- Ancient mummified child was drugged with psychedelics before ritual ... - December 14th, 2022 [December 14th, 2022]
- The therapeutic potential of psychedelics - Science - December 14th, 2022 [December 14th, 2022]
- Changing Lives with Psychedelics: How Connecticut researchers are using magic mushrooms to help people overcome depression, OCD - WTNH.com - November 19th, 2022 [November 19th, 2022]
- Penis Envy Mushroom | Legal Psychedelics | Magic Mushroom - November 7th, 2022 [November 7th, 2022]
- Psychedelics. Discussing natural and synthetic friends. Science, News ... - November 5th, 2022 [November 5th, 2022]
- The Harms of Psychedelics Need to Be Put Into Context - WIRED - November 5th, 2022 [November 5th, 2022]
- Packers' Aaron Rodgers says psychedelics led to his back-to-back MVP ... - October 28th, 2022 [October 28th, 2022]
- With Promise of Legalization, Psychedelic Companies Joust Over Future Profits - The New York Times - October 25th, 2022 [October 25th, 2022]
- How do psychedelics work? This brain region may explain their effects - PBS - October 21st, 2022 [October 21st, 2022]
- Why is the American right suddenly so interested in psychedelic drugs? - The Guardian - October 19th, 2022 [October 19th, 2022]
- Can Psychedelics Cure? Science Is on the Verge of Finding Out - Newsweek - October 19th, 2022 [October 19th, 2022]
- Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development - PsyPost - October 19th, 2022 [October 19th, 2022]
- This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More - Small Pharma - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Made the Mushrooms Magic: Psychedelic Study Explores the Odd Evolution of Mind-Altering Fungi - The Debrief - October 19th, 2022 [October 19th, 2022]
- Psychedelics And Wellness: The Healing Company Buys PepsiCo-Backed Superfoods Company - (HLCO) - Benzinga - October 19th, 2022 [October 19th, 2022]
- What's on the Colorado ballot? Housing, psychedelics, school meals, alcohol, taxes and more | FOX31 Denver - FOX 31 Denver - October 19th, 2022 [October 19th, 2022]
- DoseConnect to Sponsor the Tech Stage at Wonderland Miami by Microdose - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Is Going on With Bright Minds (DRUG) Stock Today? - InvestorPlace - October 19th, 2022 [October 19th, 2022]
- Psychedelics May Ease Fear of Death and Dying - October 17th, 2022 [October 17th, 2022]
- TDR's Top 5 Psychedelic Developments For The Week Of October 10 - The Dales Report - October 17th, 2022 [October 17th, 2022]
- DEA Wants To Boost Production Of Cannabis & Psychedelics For Research In 2023 - Benzinga - October 17th, 2022 [October 17th, 2022]
- Talk set to explore psychedelics and mental health - Reading Today - October 17th, 2022 [October 17th, 2022]
- Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- How does psilocybin rewire the brain? - Open Access Government - October 17th, 2022 [October 17th, 2022]
- HYTN Awarded Controlled Drugs and Substances Dealers License Allowing for Production and Sale of Psilocybin - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- The Healing Company acquires leading superfoods business, Your Super, and lands $150M credit facility to expand community of brands - Yahoo Finance - October 17th, 2022 [October 17th, 2022]